PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-06-12

Date Title Company
12-Jun-2025 Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease ACCESS Newswire
12-Jun-2025 BioNxt Solutions Provides Bi-Weekly MCTO Status Report ACCESS Newswire
12-Jun-2025 First of Its Kind in the Region: KFSHRC Successfully Performs Endoscopic Sleeve Gastroplasty on Kidney Transplant Patient King Faisal Specialist Hospital & Research Centre (KFSHRC)
12-Jun-2025 UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity UCB
12-Jun-2025 Augnition Labs Announces FDA Classification for Flagship Product, AugMem(TM) ACCESS Newswire
12-Jun-2025 Inovalon ONE(R), Quality Spectrum(R), Converged Risk(R), and Converged Quality(R) Named #1 by Health Plan and Managed Care Clients for Fifth Consecutive Year - Black Book Research ACCESS Newswire
12-Jun-2025 Accelerate@Babraham 2025 announces new cohort Babraham
12-Jun-2025 NHS Confederation responds to Health Secretary's speech at ConfedExpo NHS Confederation
12-Jun-2025 AlzeCure receives positive FDA response regarding Phase II/III studies with ACD440 in a rare disease AlzeCure
12-Jun-2025 Survey of 150+ Scientists by Titian Software & Labguru (BioData) Reveals Data Challenges in Lab Digitization Titian Software
12-Jun-2025 Medtech Incubator Announces Launch of New Portfolio Company: Medtech Pitch Partners ACCESS Newswire
12-Jun-2025 96% of AHIP 25 Attendees Surveyed Rank Value-Based Reimbursement Optimization as Top Priority, Black Book Pre-Event Poll ACCESS Newswire
12-Jun-2025 Henry Schein opts for IFS to optimize field service and streamline global operations IFS
12-Jun-2025 Medical Imaging Equipment Services Market Set to Surpass US$ 63.04 Billion by 2033, Driven by AI and Diagnostic Innovation" Futurewise Research
12-Jun-2025 PAUSE Live Launches National ‘Know Your Normal’ Campaign Led by Dr. Shirin PAUSE Live
12-Jun-2025 MSF Eswatini: End of HIV epidemic is within reach  MSF
12-Jun-2025 Aston University partnership will move groundbreaking medical diagnostic towards commercialisation Aston University
12-Jun-2025 Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect treatment comparison Johnson & Johnson
12-Jun-2025 Levicept to Present Further Analysis from Phase II Trial of Novel Neurotrophin-3 Inhibitor, LEVI-04, at EULAR Levicept
12-Jun-2025 Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma Enterome